While its recommended that clinicians reserve these medications for patients with a BMI of 27 or greater, she sometimes gives them to patients whose health is trending in a concerning way
Breaking through the semaglutide plateau: Your next steps
Positioned within the high-cost segment of diabetes and obesity care, these treatments face affordability challenges that directly affect patient uptake and adherence
MOTS-C is a 16-amino-acid peptide that lives inside your mitochondria, where it activates AMPK and pushes cells to burn fat for fuel
FDA approved semaglutide (brand name WEGOVY) is not (yet) registered or available in India but on request Indian patient can buy WEGOVY at the lowest price
The analysis used data from more than two million diabetes patients in the United States, including about 216,000 taking the popular drugs, to map out their risks and benefits across 175 possible health outcomes